Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05530590 · ClinicalTrials.gov registry record · NA

Minnesota Inclusive LTSS for LGBTQ Seniors

A NA study of Alzheimer Disease and Dementia, sponsored by University of Minnesota.

Active
Registry status
NA
Development phase
760
Enrollment target
1
Study location

NCT05530590 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 760 participants, below the 2,748-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05530590, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
760 participants
Enrollment target
1
Study location

Study Summary

This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.

Interventions

  • OTHER Training to Serve (TTS) in person training
  • OTHER Training to Serve online training (eTTS)

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 760 participants
Start Date 2024-01-31
Est. Completion 2026-07-04
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05530590

The ClinicalTrials.gov registry entry for NCT05530590 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 760 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (72% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Training to Serve (TTS) in person training is the first listed.

NCT05530590 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05530590 about?

NCT05530590 is a clinical study titled "Minnesota Inclusive LTSS for LGBTQ Seniors". This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlle...

What is the current status of trial NCT05530590?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 760 participants. The study started on 2024-01-31. Estimated completion is 2026-07-04.

What conditions does trial NCT05530590 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia.

What interventions are being tested in trial NCT05530590?

The interventions under investigation include: Training to Serve (TTS) in person training (OTHER), Training to Serve online training (eTTS) (OTHER).

Who is sponsoring clinical trial NCT05530590?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05530590 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.